{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:33Z","timestamp":1753891233139,"version":"3.41.2"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Accumulating evidence has shown that patients with inflammatory bowel disease (IBD) have liver function abnormalities and are susceptible to liver diseases. However, the existence of a causal relationship between IBD and liver function or disease remains unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A two-sample Mendelian randomization (MR) analysis was performed using genetic associations from publicly available genome-wide association studies (GWAS). These associations encompass ulcerative colitis (UC), Crohn\u2019s disease (CD), liver function traits, and liver disease phenotypes. The liver function traits comprised hepatic biochemistries, percent liver fat, and liver iron content from the UK Biobank. Furthermore, the liver disease phenotypes included cholelithiasis, non-alcoholic fatty liver disease (NAFLD), primary sclerosing cholangitis (PSC), and primary biliary cholangitis (PBC) in cohorts of European ancestry. The primary estimation used the inverse-variance weighted method, with GWAS of C-reactive protein (CRP) in the UK Biobank serving as a positive control outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Genetically predicted UC is causally associated with decreased levels of albumin (ALB) and liver iron content, while genetically predicted CD is causally associated with increased levels of alkaline phosphatase (ALP). Moreover, genetically predicted UC or CD increases the risk of PSC, and CD increases the risk of PBC. Neither UC nor CD causally increases the risk of cholelithiasis and NAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>UC affects the levels of ALB and liver iron content, while CD affects the levels of ALP. Both UC and CD increase the risk of PSC, and CD increases the risk of PBC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1320842","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T04:27:02Z","timestamp":1705465622000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Causal effects from inflammatory bowel disease on liver function and disease: a two-sample Mendelian randomization study"],"prefix":"10.3389","volume":"10","author":[{"given":"Yufeng","family":"Shu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bocheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanyou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/liv.13265","article-title":"Hepatic manifestations of inflammatory bowel diseases","volume":"37","author":"Restellini","year":"2017","journal-title":"Liver Int"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/apt.16879","article-title":"Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease","volume":"55","author":"Zamani","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1053\/j.gastro.2021.08.032","article-title":"Prevalence of primary Sclerosing cholangitis in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"161","author":"Barberio","year":"2021","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s12276-023-01042-9","article-title":"Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis","volume":"55","author":"Kim","year":"2023","journal-title":"Exp Mol Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/hep.21537","article-title":"Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study","volume":"45","author":"Parente","year":"2007","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1111\/liv.15616","article-title":"The causal effects of inflammatory bowel disease on primary biliary cholangitis: a bidirectional two-sample Mendelian randomization study","volume":"43","author":"Zhang","year":"2023","journal-title":"Liver Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7554\/eLife.65554","article-title":"Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning","volume":"10","author":"Liu","year":"2021","journal-title":"elife"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"100437","DOI":"10.1016\/j.xcrm.2021.100437","article-title":"Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease","volume":"2","author":"Ghodsian","year":"2021","journal-title":"Cell Rep Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jhep.2021.04.055","article-title":"An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs","volume":"75","author":"Cordell","year":"2021","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume":"49","author":"Ji","year":"2017","journal-title":"Nat Genet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/gut.21.10.870","article-title":"Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology","volume":"21","author":"Chapman","year":"1980","journal-title":"Gut"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3390\/nu15051202","article-title":"A Mendelian randomization analysis investigates causal associations between inflammatory bowel diseases and variable risk factors","volume":"15","author":"Saadh","year":"2023","journal-title":"Nutrients"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/ng.3760","article-title":"Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease","volume":"49","author":"de Lange","year":"2017","journal-title":"Nat Genet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s40001-023-01128-0","article-title":"Inflammatory bowel disease increases the levels of albuminuria and the risk of urolithiasis: a two-sample Mendelian randomization study","volume":"28","author":"Wu","year":"2023","journal-title":"Eur J Med Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/sim.7221","article-title":"A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization","volume":"36","author":"Bowden","year":"2017","journal-title":"Stat Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1572-0241.2006.00947.x","article-title":"Abnormal hepatic biochemistries in patients with inflammatory bowel disease","volume":"102","author":"Mendes","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41419-017-0124-2","article-title":"Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease","volume":"9","author":"Sartini","year":"2018","journal-title":"Cell Death Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","article-title":"Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases","volume":"23","author":"Halling","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s12072-020-10110-5","article-title":"Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease","volume":"14","author":"Azzam","year":"2020","journal-title":"Hepatol Int"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/ecco-jcc\/jjac013","article-title":"Drug-induced liver injury used in the treatment of inflammatory bowel disease","volume":"16","author":"N\u00fa\u00f1ez","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10620-020-06220-7","article-title":"Low bone mineral density in young patients newly diagnosed with inflammatory bowel disease","volume":"66","author":"Lee","year":"2021","journal-title":"Dig Dis Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2013-06-427757","article-title":"The liver: conductor of systemic iron balance","volume":"123","author":"Meynard","year":"2014","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.cgh.2011.08.027","article-title":"Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis","volume":"9","author":"Ngu","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.clinre.2019.05.002","article-title":"Primary biliary cholangitis in patients with inflammatory bowel disease","volume":"44","author":"Liberal","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1053\/j.gastro.2021.12.288","article-title":"Pattern recognition receptor Signaling and cytokine networks in microbial Defenses and regulation of intestinal barriers: implications for inflammatory bowel disease","volume":"162","author":"Abraham","year":"2022","journal-title":"Gastroenterology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1172\/JCI124884","article-title":"IFN-\u03b3 drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption","volume":"129","author":"Langer","year":"2019","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/1751-2980.12286","article-title":"Is gallstone disease associated with inflammatory bowel diseases? A meta-analysis","volume":"16","author":"Zhang","year":"2015","journal-title":"J Dig Dis"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1320842\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T04:27:05Z","timestamp":1705465625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1320842\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":36,"alternative-id":["10.3389\/fmed.2023.1320842"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1320842","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2024,1,17]]},"article-number":"1320842"}}